CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomised, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of Intravenous Imatinib Mesylate (Impentri®) in Subjects With Acute Respiratory Distress Syndrome Induced by COVID-19

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04794088
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:50.034388+00:00
Published At: 2023-01-23T00:00:00+00:00
Record Updated At: 2023-01-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["ARDS", "Acute Respiratory Distress Syndrome", "Covid19", "Endothelial Dysfunction", "Pulmonary Edema"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-01-23"
protocolSection.identificationModule.nctId: "NCT04794088"
protocolSection.identificationModule.officialTitle: "A Randomised, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of Intravenous Imatinib Mesylate (Impentri\u00ae) in Subjects With Acute Respiratory Distress Syndrome Induced by COVID-19"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.